Protopam Chloride (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Protopam Chloride drug offered from Baxter Healthcare Corporation. This Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: pralidoxime chloride
SUBSTANCE NAME: PRALIDOXIME CHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinesterase Reactivator [EPC],Cholinesterase Reactivators [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1965-03-10
END MARKETING DATE: 0000-00-00


Protopam Chloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProtopam Chloride from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/20mL)
START MARKETING DATE: 1965-03-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60977-141_e0fe9a3c-fa5a-488a-850b-6927899bc27b
PRODUCT NDC: 60977-141
APPLICATION NUMBER: NDA014134

Other PRALIDOXIME CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationProtopam Chloride
Meridian Medical Technologies, Inc.Pralidoxime Chloride